SCHEMBL19166178

SCHEMBL19166178

c1cncc(-c2cccc(-c3nc(-c4ccc(-c5ccc6c(c5)oc5ccccc56)cc4)cc(-c4ccc5oc6ccccc6c5c4)n3)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.46
▸ DHODH Q02127 1/20 0.43
▸ CYP19A1 P11511 3/20 0.43
▸ KDM4E B2RXH2 4/20 0.42
▸ MAPT P10636 4/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ HSD17B10 Q99714 3/20 0.42
▸ HPGD P15428 3/20 0.42
▸ CYP17A1 P05093 1/20 0.40
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ PIM2 Q9P1W9 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19165295 0.99 PGR (0.46) PGRDHODHCYP19A1KDM4EMAPT
SCHEMBL19166723 0.97 DHODH (0.44) PGRDHODHCYP19A1KDM4EMAPT
SCHEMBL19166730 0.96 DHODH (0.46) PGRDHODHCYP19A1KDM4EMAPT
SCHEMBL19165585 0.96 PGR (0.46) PGRDHODHCYP19A1KDM4EMAPT
SCHEMBL19165588 0.95 DHODH (0.45) PGRDHODHCYP19A1KDM4EMAPT
SCHEMBL19165284 0.95 DHODH (0.47) PGRDHODHCYP19A1KDM4EMAPT
SCHEMBL19166187 0.95 DHODH (0.47) PGRDHODHCYP19A1KDM4EMAPT
SCHEMBL19397498 0.95 DHODH (0.47) PGRDHODHCYP19A1KDM4EMAPT
SCHEMBL19165297 0.95 DHODH (0.47) PGRDHODHCYP19A1KDM4EMAPT
SCHEMBL19165303 0.94 DHODH (0.46) PGRDHODHCYP19A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10784446-B2 Compound, organic electroluminescence element material, organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-09-22 — — US disclosed
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 — — US disclosed
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10784446-B2 Compound, organic electroluminescence element material, organic electroluminescence element and electronic device L1CAM, SOD1, OR10J3 PGR 1641/4885DHODH 4336/4885CYP19A1 1111/4885
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE L1CAM, SOD1, OR10J3 PGR 1641/4885DHODH 4336/4885CYP19A1 1111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback